Common misconceptions

Common mistake
Wrong: All α1-blockers used for BPH cause equal degrees of systemic hypotension.
Right: Tamsulosin is selective for α1A receptors (predominant in prostate/bladder neck) and causes less systemic hypotension than non-selective α1-blockers like doxazosin or terazosin.
Not all α1-blockers carry the same hypotension risk. Tamsulosin preferentially binds α1A receptors, which are concentrated in the prostate and bladder neck rather than vascular smooth muscle. Doxazosin and terazosin block α1 receptors more broadly — including α1B in blood vessels — so they cause significantly more orthostatic hypotension. This is why doxazosin is actually used in hypertension, while tamsulosin is not.
Common mistake
Gap: Missing that tamsulosin causes floppy iris syndrome requiring preoperative disclosure before cataract surgery
Tamsulosin causes intraoperative floppy iris syndrome (IFIS) during cataract surgery due to α1 blockade of the iris dilator muscle, and ophthalmologists must be informed before surgery.
Tamsulosin blocks α1 receptors not just in the prostate but also in the iris dilator muscle, which relies on α1 stimulation to keep the pupil dilated under stress. When this muscle is chronically blocked, it becomes atonic — and during cataract surgery, the iris can billow, flop, and prolapse through the incision. This is intraoperative floppy iris syndrome, and it's a surgical emergency that can be anticipated and managed only if the ophthalmologist knows the patient is on tamsulosin preoperatively.
Common mistake
Wrong: Α1-blockers shrink the prostate like finasteride.
Right: α1-blockers relax smooth muscle in the prostate and bladder neck to relieve obstruction immediately, whereas finasteride reduces prostate size over months by lowering DHT.
α1-blockers don't touch prostate size — they relax the smooth muscle that's already there, reducing dynamic obstruction at the bladder neck and prostate. Symptom relief is rapid, often within days. Finasteride is a 5α-reductase inhibitor that lowers DHT and causes actual glandular atrophy over months, making it appropriate for men with significantly enlarged prostates. These are complementary mechanisms and are often combined, but they are not interchangeable.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a drug name (tamsulosin vs. doxazosin), identify the receptor subtype selectivity and predict whether significant systemic hypotension is expected as a side effect.
  2. Explain the mechanism by which α1-blockers relieve BPH symptoms — specifically, which tissue they act on and why symptoms improve quickly (within days).
  3. Recognize intraoperative floppy iris syndrome as a complication of tamsulosin in a patient undergoing cataract surgery, and understand why preoperative disclosure to the ophthalmologist is required.

Can you avoid these mistakes?

A 68-year-old man with BPH is started on tamsulosin. His friend with the same diagnosis is on doxazosin and complains of dizziness when standing up. Why does tamsulosin cause less orthostatic hypotension than doxazosin?
A urologist plans to start an elderly man with BPH on tamsulosin. The patient mentions he has a cataract surgery scheduled in 3 weeks. What complication must be disclosed to the ophthalmologist, and what is its mechanism?
A patient with BPH asks his physician, 'Will this medication shrink my prostate?' He has just been prescribed tamsulosin. What is the correct answer, and how does tamsulosin's mechanism differ from finasteride's?
A man with BPH needs rapid relief of his urinary symptoms — hesitancy and weak stream for 2 weeks. You are choosing between tamsulosin and finasteride. Which is more appropriate for rapid symptom relief and why?

Related topics

See how your Anki deck covers this topic.

Upload your deck for a free audit →